Paranovus Entertainment Technology Ltd. Class A Ordinary Shares
PAVSParanovus Entertainment Technology Ltd. Class A Ordinary Shares (PAVS) is a company involved in the entertainment and digital media industry. It focuses on leveraging innovative technology to create and distribute entertainment content, potentially including mobile gaming, digital media services, and related entertainment products. The company aims to enhance user engagement through technological advancements in entertainment experiences.
Company News
U.S. stock futures showed mixed performance on Tuesday following a preliminary U.S.-Iran agreement. The Dow Jones and Nasdaq 100 advanced while the S&P 500 fell slightly. Key movers included SpaceX surging with a market cap nearing $3 trillion, Dave and Buster's dropping 11.44% on weak earnings, Western Digital gaining 4.97% on analyst upgrade, a...
PAVS announced a $10 million registered direct offering of 50 million Class A ordinary shares at $0.20 per share. The offering is expected to close on June 16, 2026. Proceeds will be used for evaluating strategic acquisition opportunities in consumer products, wellness, fitness, lifestyle, and digital commerce sectors, as well as working capital ...
Paranovus Entertainment Technology Limited (NASDAQ: PAVS) announced a registered direct offering of approximately 14.3 million Class A ordinary shares at $0.35 per share, raising $5 million in gross proceeds. The offering is expected to close on March 25, 2026, with net proceeds intended for working capital and general corporate purposes. A.G.P./...
Paranovus Entertainment (NASDAQ: PAVS) stock surged 53.6% in after-hours trading to $0.46 following the company's announcement of terminating its at-the-market offering sales agreement with A.G.P./Alliance Global Partners, effective March 22, 2026. The company had sold 5,880,052 Class A shares under the agreement since October 2025. Despite the o...
Gainers Enzo Biochem, Inc. (NYSE: ENZ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp. Histogen Inc. (NASDAQ: HSTO) climbed 60% to $1.39 after the company announced issuance of a US patent covering CTS-2090 methods of use. QualTek Services Inc. (NASDAQ: QTEK) gained 56.4% to $0.4379. QualTek sec...
